Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chimerix
Pharma
Emergent finalizes deal for Chimerix's smallpox drug Tembexa
Emergent BioSolutions completed its acquisition of oral antiviral Tembexa from Chimerix, giving the U.S. another potential treatment for monkeypox.
Kevin Dunleavy
Sep 27, 2022 9:15am
HHS earmarks $680M for smallpox drug, an Emergent buyout target
Aug 29, 2022 11:50am
Emergent adds another arrow to its medical ountermeasures quiver
May 16, 2022 2:29pm
FDA approves Chimerix's oral suspension smallpox antiviral
Jun 8, 2021 7:30am
